Description of the age-related eye disease study 9-step severity scale applied to participants in the complications of age-related macular degeneration prevention trial

Archives of Ophthalmology

Volumn 127, Issue 9, 2009, Pages 1147-1151

  Ying, Gui Shuang ^a,c   Maguire, Maureen G ^a   Alexander, Judith ^a   Martin, Revell W ^a   Antoszyk, Andrew N ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Charlotte Eye Ear Nose and Throat   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DRUSEN; EYE DISEASE; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

ATROPHY; CHOROIDAL NEOVASCULARIZATION; DISEASE PROGRESSION; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LASER COAGULATION; MACULAR DEGENERATION; OBSERVATION; PHOTOGRAPHY; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 70349251236     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.189     Document Type: Article

References (18)

1. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004;137(3):486-495.
2. Wang JJ, Rochtchina E, Lee AJ, et al. Ten-year incidence and progression of age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology. 2007;114(1):92-98. (Pubitemid 46014292)
3. Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol. 1997;115(6):741-747.
4. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL III; Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS Report No.19. Ophthalmology. 2005;112(4):533-539. (Pubitemid 41108849)
5. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Risk factors for choroidal neovascularization and geographic atrophy in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology. 2008;115(9):1474-1479, 1479. e1-e6.
6. Davis MD, Gangnon RE, Lee LY, et al; Age-Related Eye Disease Study Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123(11):1484-1498.
7. Ferris FL, Davis MD, Clemons TE, et al; Age-Related Eye Disease Study (AREDS) Research Group. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123(11):1570-1574.
8. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387.
9. Complications of Age-Related Macular Degeneration Prevention Trial Study Group. The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology. Clin Trials. 2004;1(1):91-107.
10. Complications of Age-Related Macular Degeneration Prevention Trial Research Group. Laser treatment in patients with bilateral large drusen: the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Ophthalmology. 2006;113(11):1974-1986.
11. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol. 2001;132(5):668-681.
12. Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90(3):206-217.
13. Bressler NM, Muñoz B, Maguire MG, et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Arch Ophthalmol. 1995;113(3):301-308.
14. Abdelsalam A, Del Priore L, Zarbin MA. Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol. 1999;44(1):1-29. (Pubitemid 29378350)
15. Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye. 1994;8(pt 3):269-283. (Pubitemid 24229711)
16. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2(pt 5):552-577.
17. Klein ML, Ferris FL III, Armstrong J, et al; AREDS Research Group. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology. 2008;115(6):1026-1031. (Pubitemid 351749691)
18. Fleming TR, DeMets DL. Surrogate endpoints in clinical trials: are we being misled? Ann Intern Med. 1996;125(7):605-613.